Logo1
CCEN - 9th Practical Clinical Cytometry Course (PACE Credit)
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
Only Florida licensees need to answer this question. Notice to Florida Licensees: In order for us to report your hours to CE Broker, you MUST provide us with your Florida alpha-numberic license number (e.g., CDCA.XXXXXX, LICDCII.XXXXXX, LCDCII.XXXXXX, LICDC.XXXXXX). Please be sure to enter this number accurately, or CE Broker will not record your hours. 
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
Objective 2: After completing this event, participants also will have a better overall understanding of the field in general, related diagnostic guidelines, and hands-on analysis skills.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
Objective 3: For a number of medical and scientific societies and associations, annual meetings and symposia are a primary forum for dissemination of the latest clinical information on many aspects of patient care. As such, to provide best practices in patient care, clinicians must remain up to date on the latest findings provided by annual meetings or small focused courses such as this event.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor used technology effectively
Participants get an introductory overview on the topic, a framework for later information during the course
The instructor used technology effectively
Review the principles of daily, weekly, and monthly instrument Quality Control.
Present the steps and perform instrument optimization and compensation using software emulators that resemble actual flow cytometers
Demonstrate and run controls as a way to monitor the compensation settings
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that characterize normal maturation.
Participants will be able to describe the potential benefits and drawbacks of templates in analysis of flow cytometric data.
The instructor used technology effectively
Review the principles of daily, weekly, and monthly instrument Quality Control.
Present the steps and perform instrument optimization and compensation using software emulators that resemble actual flow cytometers
Demonstrate and run controls as a way to monitor the compensation settings
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that characterize normal maturation.
Participants will be able to describe the potential benefits and drawbacks of templates in analysis of flow cytometric data.
The instructor used technology effectively
Review the principles of daily, weekly, and monthly instrument Quality Control.
Present the steps and perform instrument optimization and compensation using software emulators that resemble actual flow cytometers
Demonstrate and run controls as a way to monitor the compensation settings
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that characterize normal maturation.
Participants will be able to describe the potential benefits and drawbacks of templates in analysis of flow cytometric data.
The instructor used technology effectively
Review the principles of daily, weekly, and monthly instrument Quality Control.
Present the steps and perform instrument optimization and compensation using software emulators that resemble actual flow cytometers
Demonstrate and run controls as a way to monitor the compensation settings
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
The instructor used technology effectively
Review of best practices based on ICCS/ESCCA PNH Guidelines - RBC
Participants will understand all aspects of PNH RBC testing including instrument setup, spreciment preparation, analysis and reporting
Participants willl understand the principals,and best pratices for the consenus recommended WBC assay to detect PNH cells
The instructor used technology effectively
Review the requirements and regulatory aspects of a CAP inspection as it pertains to the clinical flow cytometry laboratory
Present ideas for making preparation easier as well as share organizational tools that will allow for quick access to requested documentation
Participants can ask questions to a panel of experts on the topic of CAP inspections
The instructor used technology effectively
Participants will learn how to design a high dimensional flow cytometry panel
Participants will learn how to critically evaluate a flow cytometry panel for spectral crosstalk issues and population resolution
Participants will learn how to access antigen density
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate chronic lymphoid neoplasms from normal mature lymphocytes.
Participants will be able to use flow cytometric data to develop a differential diagnosis for lymphoid neoplasms.
The instructor used technology effectively
Participants will learn how to design a high dimensional flow cytometry panel
Participants will learn how to critically evaluate a flow cytometry panel for spectral crosstalk issues and population resolution
Participants will learn how to access antigen density
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate chronic lymphoid neoplasms from normal mature lymphocytes.
Participants will be able to use flow cytometric data to develop a differential diagnosis for lymphoid neoplasms.
The instructor used technology effectively
Participants will learn how to design a high dimensional flow cytometry panel
Participants will learn how to critically evaluate a flow cytometry panel for spectral crosstalk issues and population resolution
Participants will learn how to access antigen density
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate chronic lymphoid neoplasms from normal mature lymphocytes.
Participants will be able to use flow cytometric data to develop a differential diagnosis for lymphoid neoplasms.
The instructor used technology effectively
Participants will learn how to design a high dimensional flow cytometry panel
Participants will learn how to critically evaluate a flow cytometry panel for spectral crosstalk issues and population resolution
Participants will learn how to access antigen density
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate chronic lymphoid neoplasms from normal mature lymphocytes.
Participants will be able to use flow cytometric data to develop a differential diagnosis for lymphoid neoplasms.
The instructor used technology effectively
Participants will learn to identify plasma cells and differentiate them from normal B cells by flow cytometry.
Participants will learn to characterize and recognize the phenotype of normal plasma cells.
Participants will learn to differentiate abnormal plasma cells from their normal reactive counterparts, and will learn to use flow cytometry to diagnose plasma cell neoplasms.
The instructor used technology effectively
Participants will learn which antigen on plasma cells are best used to differenitate abnormal from normal plasma cells
Participants will be expoused to the consensus guidelines for high sensitivity multiple myeloma testing by flow cytometry
Participants will learn how to validate a high sensitivity asssay, evaluating LOB, LOD, and LLOQ
The instructor used technology effectively
Review of best practices based on ICCS/ESCCA PNH Guidelines - WBC
Participants will understand all aspects of PNH WBC testing including instrument setup, spreciment preparation, analysis and reporting
Participants will review the requirements for validation and discuss challenging case studies
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate acute leukemias from normal maturation.
Participants will be able to incorporate flow cytometric data to correctly classify acute leukemias.
The instructor used technology effectively
Participants will increase their knowledge of the current tools and technologies available for patient sample analysis.   
Participants will understand patterns of antigen expression that differentiate acute leukemias from normal maturation.
Participants will be able to incorporate flow cytometric data to correctly classify acute leukemias.
The instructor used technology effectively
participants will develop an understanding of the clinical singificance of AML MRD
participants will learn the current recommendations in AML MRD testing
participants will learn how to recognize immunophenotypically abnormal myeloid blasts
The instructor used technology effectively
Participants will develop an understanding of the impact of immunotherapies on interpretation of flow cytometric data
Participants will recognize characteristics of flow cytometric data that suggest prior exposure to immunotherapies.
Participants will be able to list at least 2 different types of immunotherpies and describe how they may impact flow cytometric data.
The instructor used technology effectively
We will review the evolution of methods for analysis of DNA content by flow Cytometry.
The development and use of propidium iodide/hypotonic citrate method for rapid analysis of DNA content was used for analysis of cell cycle position and aneuupllidy in human tumors and for following of bone marrow regeneration in cancer patients on high dose chemotherapy protocols.
Subsequently, we used this rapid method for analysis of DNA content in plants and animals from the Miami Zoo. To diagonse the possible histological origin of suspicious cancer cells in body cavity fluids, we combined the PI/hypotonic citrate method with marker expression for multiparametric flow analysis.
The instructor used technology effectively
Participants will be able to address preanalytic, analytic, and postanalytic troubleshooting issues along with ways to prevent problems before they arise
participants will be presented with cases to troubleshoot. With this in hand they will be able to recognize the problem if it arises and will know where to look for solutions
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities and facility accommodations.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
Please tell us about any sessions you found particularly good or bad
Please tell us about any objectives you feel we accomplished well or poorly 
Please tell us about any presenters you found particularly good or bad
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question
Provided by amedco